Headlines

Banco Bradesco And FibroGen On The List Of Winners And Losers Of Wednesday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Banco Bradesco, Sorrento Therapeutics, and America Movil.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Banco Bradesco (BBDO) 2.43 4.29% 2023-02-15 04:10:27
2 Sorrento Therapeutics (SRNE) 0.20 2.33% 2023-02-15 07:31:09
3 America Movil (AMX) 20.49 2.04% 2023-02-15 04:09:40
4 U.S. Gold Corp (USAU) 4.40 1.85% 2023-02-15 04:19:51
5 Rock (RKT) 8.99 1.58% 2023-02-15 07:19:02
6 Sypris Solutions (SYPR) 2.05 0.99% 2023-02-15 07:07:36
7 Tattooed Chef (TTCF) 1.35 0.75% 2023-02-15 04:40:58
8 Ambev (ABEV) 2.50 0.4% 2023-02-15 04:09:17
9 Aurora Cannabis (ACB) 0.93 0.4% 2023-02-15 07:23:04
10 Kodak (KODK) 3.66 0.27% 2023-02-15 04:15:44

The three biggest losers today are FibroGen, ING Group, and Sumitomo Mitsui.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 FibroGen (FGEN) 24.00 -2.28% 2023-02-15 04:11:33
2 ING Group (ING) 13.87 -1.84% 2023-02-15 07:30:09
3 Sumitomo Mitsui (SMFG) 8.66 -1.81% 2023-02-15 04:19:25
4 Southern Copper (SCCO) 73.50 -1.66% 2023-02-15 07:04:25
5 GlaxoSmithKline (GSK) 35.47 -1.64% 2023-02-15 07:29:24
6 Globalstar (GSAT) 1.21 -1.63% 2023-02-15 07:23:00
7 Yamana Gold (AUY) 5.48 -1.62% 2023-02-15 07:25:08
8 Mizuho Financial Group (MFG) 3.20 -1.54% 2023-02-15 04:43:05
9 ENI S.p.A. (E) 31.56 -1.47% 2023-02-15 04:28:08
10 Brookfield Infrastructure Partners (BIP) 34.46 -1.46% 2023-02-15 04:10:41

Premarket Winners today

1. Banco Bradesco (BBDO) – Premarket: 4.29%

Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil. Banco Bradesco S.A. is a subsidiary of Cidade de Deus – Companhia Comercial de Participações.

NYSE ended the session with Banco Bradesco jumping 0.95% to $2.33 on Wednesday, after two successive sessions in a row of gains. NYSE fell 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.299.

PE Ratio

Banco Bradesco has a trailing twelve months price to earnings ratio of 7.8. Meaning, the purchaser of the share is investing $7.8 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.4%.

Yearly Top and Bottom Value

Banco Bradesco’s stock is valued at $2.33 at 07:34 EST, way under its 52-week high of $3.90 and above its 52-week low of $2.29.

Volatility

Banco Bradesco’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.55%, a negative 0.56%, and a positive 2.17%.

Banco Bradesco’s highest amplitude of average volatility was 3.35% (last week), 2.10% (last month), and 2.17% (last quarter).

Volume

Today’s last reported volume for Banco Bradesco is 13809 which is 48.87% below its average volume of 27011.

More news about Banco Bradesco.

2. Sorrento Therapeutics (SRNE) – Premarket: 2.33%

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.

NASDAQ ended the session with Sorrento Therapeutics falling 22.67% to $0.20 on Wednesday, after two consecutive sessions in a row of losses. NASDAQ jumped 0.57% to $11,960.15, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -326.72%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 15.2%, now sitting on 54.98M for the twelve trailing months.

Volatility

Sorrento Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 11.82%, a negative 2.95%, and a positive 5.47%.

Sorrento Therapeutics’s highest amplitude of average volatility was 12.54% (last week), 5.49% (last month), and 5.47% (last quarter).

Moving Average

Sorrento Therapeutics’s value is way under its 50-day moving average of $1.07 and way under its 200-day moving average of $1.68.

More news about Sorrento Therapeutics.

3. America Movil (AMX) – Premarket: 2.04%

América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally. The company offers wireless and fixed voice services, including local, domestic, and international long-distance services; and network interconnection services. It also provides data services, such as data centers, data administration, and hosting services to residential and corporate clients; value-added services, including Internet access, messaging, and other wireless entertainment and corporate services; data transmission, email services, instant messaging, content streaming, and interactive applications; and wireless security services, mobile payment solutions, machine-to-machine services, mobile banking, virtual private network services, and video calls and personal communications services. In addition, the company offers residential broadband services; IT solutions for small businesses and large corporations; and cable and satellite pay television subscriptions. Further, it sells equipment, accessories, and computers; and offers telephone directories, wireless security, call center, advertising, media, and software development services. Additionally, the company provides video, audio, and other media content through the Internet directly from the content provider to the end user. It sells its products and services under the Telcel, Telmex Infinitum, and A1 brands through a network of retailers and service centers to retail customers; and through sales force to corporate customers. As of December 31, 2021, the company had approximately 286.5 million wireless voice and data subscribers. América Móvil, S.A.B. de C.V. was incorporated in 2000 and is based in Mexico City, Mexico.

NYSE ended the session with America Movil rising 0.17% to $20.08 on Wednesday while NYSE fell 0.17% to $16,025.11.

Earnings Per Share

As for profitability, America Movil has a trailing twelve months EPS of $1.16.

PE Ratio

America Movil has a trailing twelve months price to earnings ratio of 17.31. Meaning, the purchaser of the share is investing $17.31 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.78%.

More news about America Movil.

4. U.S. Gold Corp (USAU) – Premarket: 1.85%

U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 650 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 87 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project that consists of 103 unpatented mining claims covering approximately 3 square miles in Eureka County, Nevada. The company is based in Elko, Nevada.

NASDAQ ended the session with U.S. Gold Corp jumping 3.85% to $4.32 on Wednesday, after four consecutive sessions in a row of gains. NASDAQ jumped 0.57% to $11,960.15, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, U.S. Gold Corp has a trailing twelve months EPS of $-4.367.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.96%.

More news about U.S. Gold Corp.

5. Rock (RKT) – Premarket: 1.58%

Rocket Companies, Inc., a fintech holding company, provides mortgage lending, title and settlement services, and other financial technology services in the United States and Canada. It operates through two segments, Direct to Consumer and Partner Network. The company's solutions include Rocket Mortgage, a mortgage lender; Amrock that provides title insurance, property valuation, and settlement services; Rocket Homes, a home search platform and real estate agent referral network, which offers technology-enabled services to support the home buying and selling experience; Rocket Auto, an automotive retail marketplace that provides centralized and virtual car sales support to online car purchasing platforms; and Rocket Loans, an online-based personal loans business. It also offers Core Digital Media, a digital social and display advertiser in the mortgage, insurance, and education sectors; Rocket Solar, which connect homeowners with digital financing solutions through a team of trained solar advisors; Rocket Money, a personal finance app that helps clients manage every aspect of their financial lives; Lendesk, a technology services company that provides a point of sale system for mortgage professionals and a loan origination system for private lenders; and Edison Financial, a digital mortgage broker. In addition, the company originates, closes, sells, and services agency-conforming loans. Rocket Companies, Inc. was founded in 1985 and is headquartered in Detroit, Michigan. Rocket Companies, Inc. operates as a subsidiary of Rock Holdings, Inc.

NYSE ended the session with Rock dropping 0.28% to $8.85 on Wednesday, after two consecutive sessions in a row of losses. NYSE slid 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Rock has a trailing twelve months EPS of $3.03.

PE Ratio

Rock has a trailing twelve months price to earnings ratio of 2.92. Meaning, the purchaser of the share is investing $2.92 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.74%.

More news about Rock.

6. Sypris Solutions (SYPR) – Premarket: 0.99%

Sypris Solutions, Inc. provides truck components, oil and gas pipeline components, and aerospace and defense electronics primarily in North America and Mexico. It operates in two segments, Sypris Technologies and Sypris Electronics. The Sypris Technologies segment supplies forged, machined, welded, and heat-treated steel components for the commercial vehicle, off highway vehicle, recreational vehicle, automotive, industrial, light truck, and energy markets. This segment also offers drive train components, including axle shafts, transmission shafts, gear sets, steer axle knuckles, and other components for automotive, truck, and recreational vehicle manufacturers. In addition, it provides value added operations for drive train assemblies; and manufactures pressure closures and other fabricated products for oil and gas pipelines. The Sypris Electronics segment offers electronic manufacturing services, such as circuit card and full box build manufacturing, high reliability manufacturing, systems assembly and integration, design for manufacturability, and design for specification work for aerospace and defense electronics markets. This segment also provides circuit card assembly services for electronic sensors and systems, including radar systems, tactical ground stations, navigation systems, weapons systems, and targeting and warning systems; and value-added solutions, such as low-volume prototype assembly and high-volume turnkey manufacturing. The company also offers engineering design and repair or inspection services. In addition, it sells its engineered product under the Tube Turns brand. The company was incorporated in 1997 and is headquartered in Louisville, Kentucky.

NASDAQ ended the session with Sypris Solutions jumping 0.74% to $2.04 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.57% to $11,960.15, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Sypris Solutions has a trailing twelve months EPS of $0.079.

PE Ratio

Sypris Solutions has a trailing twelve months price to earnings ratio of 25.76. Meaning, the purchaser of the share is investing $25.76 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.82%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.9%, now sitting on 106.21M for the twelve trailing months.

More news about Sypris Solutions.

7. Tattooed Chef (TTCF) – Premarket: 0.75%

Tattooed Chef, Inc., a plant-based food company, produces and sells a portfolio of frozen foods. It supplies plant-based products to retailers in the United States. The company offers ready-to-cook bowls, zucchini spirals, riced cauliflower, acai and smoothie bowls, cauliflower crust pizza, and plant-based burgers. Its products are available in private label and Tattooed Chef brand name in the frozen food section of retail food stores. As of December 31, 2021, it operated approximately 14,000 retail outlets. Tattooed Chef, Inc. is headquartered in Paramount, California.

NASDAQ ended the session with Tattooed Chef jumping 1.52% to $1.34 on Wednesday, after five successive sessions in a row of gains. NASDAQ jumped 0.57% to $11,960.15, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Tattooed Chef has a trailing twelve months EPS of $-0.069.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.9%.

More news about Tattooed Chef.

8. Ambev (ABEV) – Premarket: 0.4%

Ambev S.A., through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. The company operates through four segments: Brazil; Central America and the Caribbean; Latin America South; and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Cacique, Presidente, Brahma Light, Presidente Light, Presidente Golden Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, and Budweiser, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi, Canada Dry, Squirt, Red Rock, Pepsi-Cola, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. is a subsidiary of Interbrew International B.V.

NYSE ended the session with Ambev dropping 0.8% to $2.49 on Wednesday while NYSE fell 0.17% to $16,025.11.

Earnings Per Share

As for profitability, Ambev has a trailing twelve months EPS of $0.132.

PE Ratio

Ambev has a trailing twelve months price to earnings ratio of 18.86. Meaning, the purchaser of the share is investing $18.86 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.08%.

Sales Growth

Ambev’s sales growth is 17.2% for the ongoing quarter and 5.7% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 79.03B for the twelve trailing months.

More news about Ambev.

9. Aurora Cannabis (ACB) – Premarket: 0.4%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis jumping 1.57% to $0.93 on Wednesday while NYSE fell 0.17% to $16,025.11.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-15.749.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.38%.

Volume

Today’s last reported volume for Aurora Cannabis is 4911190 which is 49.47% below its average volume of 9719810.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.5%, now sitting on 230.68M for the twelve trailing months.

Sales Growth

Aurora Cannabis’s sales growth for the next quarter is 1.7%.

More news about Aurora Cannabis.

10. Kodak (KODK) – Premarket: 0.27%

Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment provides electrophotographic printing solutions, such as The ASCEND and NEXFINITY printers; prosper products, including the PROSPER 6000 Press, PROSPER Writing Systems, PROSPER press systems, and PROSPER components; versamark products; and PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company engages in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.

NYSE ended the session with Kodak jumping 2.82% to $3.65 on Wednesday while NYSE fell 0.17% to $16,025.11.

Earnings Per Share

As for profitability, Kodak has a trailing twelve months EPS of $-9.774.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.67%.

Moving Average

Kodak’s worth is way below its 50-day moving average of $4.14 and way under its 200-day moving average of $5.05.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Kodak’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 1.2B for the twelve trailing months.

More news about Kodak.

Premarket Losers Today

1. FibroGen (FGEN) – Premarket: -2.28%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen jumping 0.04% to $24.56 on Wednesday while NASDAQ rose 0.57% to $11,960.15.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-2.11.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -184.78%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FibroGen’s stock is considered to be oversold (<=20).

Volatility

FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was 0.08%, 0.89%, and 2.86%.

FibroGen’s highest amplitude of average volatility was 0.62% (last week), 2.29% (last month), and 2.86% (last quarter).

More news about FibroGen.

2. ING Group (ING) – Premarket: -1.84%

ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Germany, Poland, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts; and offers business lending products, as well as consumer lending products, such as residential mortgage loans, term loans, and revolver and personal loans. It also provides debt capital market, working capital, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, equity market, finance, payments and cash management, and trade services and solutions, as well as savings, investment, insurance, mortgage, and digital banking services. The company serves customers, corporate clients, and financial institutions, including small and medium-sized, and mid-corporates. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.

NYSE ended the session with ING Group jumping 0.28% to $14.13 on Wednesday while NYSE slid 0.17% to $16,025.11.

Earnings Per Share

As for profitability, ING Group has a trailing twelve months EPS of $0.77.

PE Ratio

ING Group has a trailing twelve months price to earnings ratio of 18.4. Meaning, the purchaser of the share is investing $18.4 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.45%.

Moving Average

ING Group’s worth is way higher than its 50-day moving average of $12.21 and way higher than its 200-day moving average of $10.31.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Aug 11, 2022, the estimated forward annual dividend rate is 0.35 and the estimated forward annual dividend yield is 3.55%.

More news about ING Group.

3. Sumitomo Mitsui (SMFG) – Premarket: -1.81%

Sumitomo Mitsui Financial Group, Inc., together with its subsidiaries, provides commercial banking, leasing, securities, consumer finance, and other services in Japan, the Americas, Europe, the Middle East, Asia, and Oceania. It operates through four segments: Wholesale Business Unit, Retail Business Unit, Global Business Unit, and Global Markets Business Unit. The Wholesale Business Unit segment offers financing, investment management, risk hedging, and settlement services, as well as financial solutions related to mergers and acquisition, and other advisory services primarily for large, mid, and small-sized corporate clients; various leasing services, including equipment, and operating and leveraged leasing; and digital services, such as robotic process automation and electronic contract services. The Retail Business Unit segment offers wealth management, settlement, consumer finance, and housing loan products and services, as well as business and asset succession services to high-net-worth customers. The Global Business Unit segment offers loans, deposits, clearing services, trade finance, project finance, loan syndication, derivatives, and cash management services; underwriting services; and leasing services related to the construction machinery, transportation equipment, industrial machinery, medical equipment, and aircraft leasing. The Global Markets Business Unit segment offers solutions through foreign exchange products, derivatives, bonds, stocks, and other marketable financial products. It also undertakes asset liability management operations. The company also offers credit card, internet banking, system development and engineering, data processing, management consulting and economic research, and investment advisory and investment trust management services. Sumitomo Mitsui Financial Group, Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan.

NYSE ended the session with Sumitomo Mitsui falling 0% to $8.82 on Wednesday, after two successive sessions in a row of losses. NYSE slid 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Sumitomo Mitsui has a trailing twelve months EPS of $0.05.

PE Ratio

Sumitomo Mitsui has a trailing twelve months price to earnings ratio of 185.33. Meaning, the purchaser of the share is investing $185.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.62%.

Volatility

Sumitomo Mitsui’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.61%, a negative 0.15%, and a positive 1.41%.

Sumitomo Mitsui’s highest amplitude of average volatility was 0.61% (last week), 1.20% (last month), and 1.41% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sumitomo Mitsui’s stock is considered to be oversold (<=20).

More news about Sumitomo Mitsui.

4. Southern Copper (SCCO) – Premarket: -1.66%

Southern Copper Corporation engages in mining, exploring, smelting, and refining copper and other minerals in Peru, Mexico, Argentina, Ecuador, and Chile. The company is involved in the mining, milling, and flotation of copper ore to produce copper and molybdenum concentrates; smelting of copper concentrates to produce blister and anode copper; refining of anode copper to produce copper cathodes; production of molybdenum concentrate and sulfuric acid; production of refined silver, gold, and other materials; and mining and processing of zinc and lead. It operates the Toquepala and Cuajone open-pit mines, and a smelter and refinery in Peru; and La Caridad, an open-pit copper mine, as well as a copper ore concentrator, a SX-EW plant, a smelter, refinery, and a rod plant in Mexico. The company also operates Buenavista, an open-pit copper mine, as well as two copper concentrators and two operating SX-EW plants in Mexico. In addition, it operates five underground mines that produce zinc, lead, copper, silver, and gold; a coal mine that produces coal and coke; and a zinc refinery. The company has interests in 82,134 hectares of exploration concessions in Peru; 493,533 hectares of exploration concessions in Mexico; 246,346 hectares of exploration concessions in Argentina; 29,888 hectares of exploration concessions in Chile; and 7,299 hectares of exploration concessions in Ecuador. Southern Copper Corporation was incorporated in 1952 and is based in Phoenix, Arizona. Southern Copper Corporation operates as a subsidiary of Americas Mining Corporation.

NYSE ended the session with Southern Copper rising 1.38% to $74.74 on Wednesday, after four consecutive sessions in a row of gains. NYSE fell 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Southern Copper has a trailing twelve months EPS of $2.74.

PE Ratio

Southern Copper has a trailing twelve months price to earnings ratio of 27.27. Meaning, the purchaser of the share is investing $27.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.42%.

Sales Growth

Southern Copper’s sales growth for the next quarter is negative 2.3%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 46.4% and a negative 26.9%, respectively.

Yearly Top and Bottom Value

Southern Copper’s stock is valued at $74.74 at 07:34 EST, under its 52-week high of $79.32 and way above its 52-week low of $42.42.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Southern Copper’s stock is considered to be overbought (>=80).

More news about Southern Copper.

5. GlaxoSmithKline (GSK) – Premarket: -1.64%

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

NYSE ended the session with GlaxoSmithKline sliding 0.48% to $36.06 on Wednesday, following the last session’s downward trend. NYSE fell 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $2.88.

PE Ratio

GlaxoSmithKline has a trailing twelve months price to earnings ratio of 12.52. Meaning, the purchaser of the share is investing $12.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.71%.

Sales Growth

GlaxoSmithKline’s sales growth for the next quarter is negative 37.9%.

Volume

Today’s last reported volume for GlaxoSmithKline is 5246260 which is 8.74% above its average volume of 4824150.

Volatility

GlaxoSmithKline’s last week, last month’s, and last quarter’s current intraday variation average was 0.04%, 0.12%, and 1.07%.

GlaxoSmithKline’s highest amplitude of average volatility was 0.86% (last week), 0.90% (last month), and 1.07% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 37.24B for the twelve trailing months.

More news about GlaxoSmithKline.

6. Globalstar (GSAT) – Premarket: -1.63%

Globalstar, Inc. provides mobile satellite services worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational usage, safety, emergency preparedness and response, and other applications; fixed voice and data satellite communications services and equipment at industrial, commercial, and residential sites, as well as rural villages and ships; and data modem services and equipment. It also provides SPOT consumer retail products, such as SPOT satellite GPS messenger for personal tracking, emergency location, and messaging solutions; and SPOT Trace, an anti-theft and asset tracking device. In addition, the company offers commercial Internet of Things one-way transmission products to track cargo containers and rail cars, as well as to monitor utility meters, and oil and gas assets. Further, it sells wholesale minutes to independent gateway operators (IGOs); and provides engineering services, such as hardware and software designs to develop specific applications; and installation of gateways and antennas. The company distributes its products directly, as well as through independent agents, dealers and resellers, retailers, IGOs, and sales force and e-commerce Website. As of December 31, 2020, it had approximately 745,000 subscribers. The company primarily serves recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, construction, utilities, and transportation, as well as natural resources, mining, and forestry markets. Globalstar, Inc. has a strategic alliance with XCOM Labs to jointly commercialize XCOM's capacity-multiplying technology with Globalstar's Band n53 for 5G deployments in the United States and other countries where Globalstar has terrestrial rights. The company was founded in 1993 and is headquartered in Covington, Louisiana.

NYSE ended the session with Globalstar jumping 2.5% to $1.23 on Wednesday, after two successive sessions in a row of gains. NYSE fell 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Globalstar has a trailing twelve months EPS of $-0.07.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Globalstar’s stock is considered to be overbought (>=80).

Sales Growth

Globalstar’s sales growth is negative 13.3% for the ongoing quarter and negative 13.7% for the next.

More news about Globalstar.

7. Yamana Gold (AUY) – Premarket: -1.62%

Yamana Gold Inc., together with its subsidiaries, operates as a precious metal producer. It has gold and silver production, development-stage properties, exploration properties, and land positions throughout the Americas, including Canada, Brazil, Chile, and Argentina. The company was formerly known as Yamana Resources Inc. and changed its name to Yamana Gold Inc. in August 2003. Yamana Gold Inc. was founded in 2003 and is headquartered in Toronto, Canada.

NYSE ended the session with Yamana Gold rising 0.36% to $5.57 on Wednesday while NYSE fell 0.17% to $16,025.11.

Earnings Per Share

As for profitability, Yamana Gold has a trailing twelve months EPS of $0.22.

PE Ratio

Yamana Gold has a trailing twelve months price to earnings ratio of 25.32. Meaning, the purchaser of the share is investing $25.32 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.83%.

More news about Yamana Gold.

8. Mizuho Financial Group (MFG) – Premarket: -1.54%

Mizuho Financial Group, Inc., together with its subsidiaries, engages in banking, trust, securities, and other businesses related to financial services in Japan, the Americas, Europe, Asia/Oceania, and internationally. It operates through five segments: Retail & Business Banking Company, Corporate & Institutional Company, Global Corporate Company, Global Markets Company, and Asset Management Company. The company provides deposit products; syndicated, housing, and card loans; business matching services; and advisory services related to overseas expansions, and mergers and acquisitions-related services. It also offers consulting services, including asset management and asset succession; payroll services; and sells lottery tickets issued by prefectures and ordinance-designated cities. In addition, it offers financial solutions, such as bonds, mergers and acquisitions advisory, risk hedging products, etc. for corporate customers to meet their needs in fund-raising, investment management, and financial strategies; solutions based on their capital management, business strategy, and financial strategy; real estate agency services; advisory services and solutions, such as advice on proposals on various investment products to financial institutions; and financial services that include funding support and public bonds underwriting. Further, the company offers sales and trading services to meet needs for customers; investment products for individual customers; and consulting services for institutional investors. Additionally, the company provides products and services related to trust, securitization and structured finance, pension, and stock transfers; securities services; and research, private banking, and information technology-related services. Mizuho Financial Group, Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.

NYSE ended the session with Mizuho Financial Group jumping 0.78% to $3.25 on Wednesday, after two consecutive sessions in a row of gains. NYSE slid 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Mizuho Financial Group has a trailing twelve months EPS of $0.2884.

PE Ratio

Mizuho Financial Group has a trailing twelve months price to earnings ratio of 11.25. Meaning, the purchaser of the share is investing $11.25 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.9%.

Yearly Top and Bottom Value

Mizuho Financial Group’s stock is valued at $3.25 at 07:34 EST, below its 52-week high of $3.30 and way above its 52-week low of $2.10.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 2.48T for the twelve trailing months.

Volatility

Mizuho Financial Group’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.16%, a negative 0.13%, and a positive 1.74%.

Mizuho Financial Group’s highest amplitude of average volatility was 1.42% (last week), 1.59% (last month), and 1.74% (last quarter).

Moving Average

Mizuho Financial Group’s value is way above its 50-day moving average of $2.70 and way higher than its 200-day moving average of $2.41.

More news about Mizuho Financial Group.

9. ENI S.p.A. (E) – Premarket: -1.47%

Eni S.p.A. engages in the exploration, development, and production of crude oil and natural gas. It operates through Exploration & Production; Global Gas & LNG Portfolio; Refining & Marketing and Chemicals; Plenitude and Power; and Corporate and Other activities segments. The Exploration & Production segment is involved in the research, development, and production of oil, condensates and natural gas; and forestry conservation and CO2 capture and storage projects. The Global Gas & LNG Portfolio segment engages in the supply and wholesale of natural gas by pipeline, international transport; and purchase and marketing of LNG. The Refining & Marketing and Chemicals segment is involved in the processing, supply, distribution, and marketing of fuels and chemicals. The Eni gas e luce, Power & Renewables segment engages in the retail sales of gas, electricity, and related activities, as well as in the production and wholesale of electricity produced by thermoelectric and renewable plants. As of December 31, 2021, it had net proved reserves of 6,628 million barrels of oil equivalent; and installed operational capacity of 4.5 GW. The company was founded in 1953 and is headquartered in Rome, Italy.

NYSE ended the session with ENI S.p.A. rising 0.97% to $32.03 on Wednesday, after five consecutive sessions in a row of gains. NYSE fell 0.17% to $16,025.11, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, ENI S.p.A. has a trailing twelve months EPS of $-5.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.26%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Nov 20, 2022, the estimated forward annual dividend rate is 1.81 and the estimated forward annual dividend yield is 5.97%.

More news about ENI S.p.A..

10. Brookfield Infrastructure Partners (BIP) – Premarket: -1.46%

Brookfield Infrastructure Partners L.P. owns and operates utilities, transport, midstream, and data businesses in North and South America, Europe, and the Asia Pacific. The company's Utilities segment operates approximately 61,000 kilometers (km) of operational electricity transmission and distribution lines; 5,300 km of electricity transmission lines; 4,200 km of natural gas pipelines; 7.3 million electricity and natural gas connections; and 360,000 long-term contracted sub-metering services. This segment also offers heating and cooling solutions; gas distribution; water heaters; and heating, ventilation, and air conditioner rental, as well as other home services. Its Transport segment offers transportation, storage, and handling services for merchandise goods, commodities, and passengers through a network of approximately 22,000 km of track; 5,500 km of track network; 4,800 km of rail; 3,800 km of motorways; and 13 port terminals. The company's Midstream segment offers natural gas transmission, gathering and processing, and storage services through approximately 15,000 km of natural gas transmission pipelines; 600 billion cubic feet of natural gas storage; 17 natural gas processing plants; and 3,900 km of gas gathering pipelines, as well as one petrochemical processing complex. Its Data segment operates approximately 148,000 operational telecom towers; 8,000 multi-purpose towers and active rooftop sites; 10,000 km of fiber backbone; 1,600 cell sites and approximately 12,000 km of fiber optic cable; and 2,100 active telecom towers and 70 distributed antenna systems, as well as 50 data centers and 200 megawatts of critical load capacity. The company was founded in 2007 and is based in Hamilton, Bermuda. Brookfield Infrastructure Partners L.P. is a subsidiary of Brookfield Asset Management Inc.

NYSE ended the session with Brookfield Infrastructure Partners jumping 1.94% to $34.97 on Wednesday while NYSE slid 0.17% to $16,025.11.

Earnings Per Share

As for profitability, Brookfield Infrastructure Partners has a trailing twelve months EPS of $0.41.

PE Ratio

Brookfield Infrastructure Partners has a trailing twelve months price to earnings ratio of 85.07. Meaning, the purchaser of the share is investing $85.07 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.24%.

Sales Growth

Brookfield Infrastructure Partners’s sales growth is negative 22.9% for the ongoing quarter and negative 25.9% for the next.

Yearly Top and Bottom Value

Brookfield Infrastructure Partners’s stock is valued at $34.97 at 07:34 EST, way under its 52-week high of $46.01 and way above its 52-week low of $30.03.

More news about Brookfield Infrastructure Partners.

Stay up to date with our premarket winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *